Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018

INTRODUCTION: Twice-daily (BID) thoracic radiotherapy (TRT) of 45 Gy per 30 fractions is recommended for limited-stage (LS) SCLC, but most patients are treated with once-daily (OD) schedules owing to toxicity concerns and logistic challenges. An alternative is hypofractionated OD TRT of 40 to 42 Gy...

Descripción completa

Detalles Bibliográficos
Autores principales: Graabak, Gustav, Grønberg, Bjørn Henning, Sandvei, Marie Søfteland, Nilssen, Yngvar, Halvorsen, Tarje Onsøien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801751/
https://www.ncbi.nlm.nih.gov/pubmed/35146461
http://dx.doi.org/10.1016/j.jtocrr.2021.100270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801751/
https://www.ncbi.nlm.nih.gov/pubmed/35146461
http://dx.doi.org/10.1016/j.jtocrr.2021.100270

Ejemplares similares